Paper10754451
Role of oxidative stress and glutathione in busulfan toxicity in cultured murine hepatocytes.
DeLeve LD and 1 other. Pharmacology, 2000. Cited by 97 papers, by iCite.
Cite this record
ConductScience Library. Role of oxidative stress and glutathione in busulfan toxicity in cultured murine hepatocytes. Papers, record 10754451. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/10754451
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Role of oxidative stress and glutathione in busulfan toxicity in cultured murine hepatocytes.
- PubMed
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Alkylating Agents | Major topic |
| Busulfan | Major topic |
| Glutathione | Major topic |
| Liver | Major topic |
| Oxidative Stress | Major topic |
| Animals | |
| Cells, Cultured | |
| Male | |
| Mice | |
| Mice, Inbred C3H | |
| Thiobarbituric Acid Reactive Substances |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| DK 46357 | NIDDK NIH HHS | United States | R01DK046357 | PubMed and NIH | NIH RePORTER |
| R29DK046357 | NIH | NIH RePORTER |
Cited by49
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 97 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41896325 | Risk factors for alloimmune lung syndromes after allogeneic hematopoietic cell transplantation in children. | Bone Marrow Transplant | 2026 | https://conductscience.org/library/papers/41896325 | PubMed |
| 41730941 | Busulfan resistance in AML is associated with changes in mitochondrial copy number and lipid metabolism. | Sci Rep | 2026 | https://conductscience.org/library/papers/41730941 | PubMed |
| 39408056 | Management of Busulfan-Induced Lung Injury in Pediatric Patients with High-Risk Neuroblastoma. | J Clin Med | 2024 | https://conductscience.org/library/papers/39408056 | PubMed |
| 38966316 | Cyclophosphamide Pharmacogenomic Variation in Cancer Treatment and Its Effect on Bioactivation and Pharmacokinetics. | Adv Pharmacol Pharm Sci | 2024 | https://conductscience.org/library/papers/38966316 | PubMed |
| 38936939 | In Vivo Cytotoxic, Genotoxic and Radiosensitizing Effects of Clofarabine. | In Vivo | 2024 | https://conductscience.org/library/papers/38936939 | PubMed |
| 38458191 | Restoration of fertility in nonablated recipient mice after spermatogonial stem cell transplantation. | Stem Cell Reports | 2024 | https://conductscience.org/library/papers/38458191 | PubMed |
| 38276491 | Population Pharmacokinetic Modeling for Twice-Daily Intravenous Busulfan in a Large Cohort of Pediatric Patients Undergoing Hematopoietic Stem Cell Transplantation-A 10-Year Single-Center Experience. | Pharmaceutics | 2023 | https://conductscience.org/library/papers/38276491 | PubMed |
| 37899250 | WIN18,446 enhances spermatogonial stem cell homing and fertility after germ cell transplantation by increasing blood-testis barrier permeability. | J Reprod Dev | 2023 | https://conductscience.org/library/papers/37899250 | PubMed |
| 37086290 | Hypofibrinolysis in pediatric patients with veno-occlusive disease in hematopoietic stem cell transplantation. | J Cancer Res Clin Oncol | 2023 | https://conductscience.org/library/papers/37086290 | PubMed |
| 37085674 | Effect of pharmacokinetics and pharmacogenomics in adults with allogeneic hematopoietic cell transplantation conditioned with Busulfan. | Bone Marrow Transplant | 2023 | https://conductscience.org/library/papers/37085674 | PubMed |
| 36834506 | Alginate Oligosaccharides Repair Liver Injury by Improving Anti-Inflammatory Capacity in a Busulfan-Induced Mouse Model. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/36834506 | PubMed |
| 35611997 | Population pharmacokinetic model for once-daily intravenous busulfan in pediatric subjects describing time-associated clearance. | CPT Pharmacometrics Syst Pharmacol | 2022 | https://conductscience.org/library/papers/35611997 | PubMed |
| 35361896 | Impact of busulfan pharmacokinetics on outcome in adult patients receiving an allogeneic hematopoietic cell transplantation. | Bone Marrow Transplant | 2022 | https://conductscience.org/library/papers/35361896 | PubMed |
| 34499222 | GSTM1 and GSTT1 double null genotypes determining cell fate and proliferation as potential risk factors of relapse in children with hematological malignancies after hematopoietic stem cell transplantation. | J Cancer Res Clin Oncol | 2022 | https://conductscience.org/library/papers/34499222 | PubMed |
| 33384597 | NRF2 -617 C/A Polymorphism Impacts Proinflammatory Cytokine Levels, Survival, and Transplant-Related Mortality After Hematopoietic Stem Cell Transplantation in Adult Patients Receiving Busulfan-Based Conditioning Regimens. | Front Pharmacol | 2020 | https://conductscience.org/library/papers/33384597 | PubMed |
| 33128207 | Review of the Pharmacokinetics and Pharmacodynamics of Intravenous Busulfan in Paediatric Patients. | Clin Pharmacokinet | 2021 | https://conductscience.org/library/papers/33128207 | PubMed |
| 33098041 | Busulfan-cyclophosphamide versus cyclophosphamide-busulfan as conditioning regimen before allogeneic hematopoietic cell transplantation: a prospective randomized trial. | Ann Hematol | 2021 | https://conductscience.org/library/papers/33098041 | PubMed |
| 33064008 | Prediction of Acute Graft versus Host Disease and Relapse by Endogenous Metabolomic Compounds in Patients Receiving Personalized Busulfan-Based Conditioning. | J Proteome Res | 2021 | https://conductscience.org/library/papers/33064008 | PubMed |
| 33024523 | Evaluation of Reversed Administration Order of Busulfan (BU) and Cyclophosphamide (CY) as Conditioning on Liver Toxicity in Allogenic Hematopoietic Stem Cell Transplantation (ALL-HSCT). | Int J Hematol Oncol Stem Cell Res | 2020 | https://conductscience.org/library/papers/33024523 | PubMed |
| 32318059 | Diagnosis and Treatment of VOD/SOS After Allogeneic Hematopoietic Stem Cell Transplantation. | Front Immunol | 2020 | https://conductscience.org/library/papers/32318059 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/10754451
GET https://conductscience.org/api/papers/v1/10754451/cited_by?page=2